Dynamic value assessmentRapid decision makingSustainable P&MA researchComplete P&MA strategyPrice forecasting

GPI Horizon

Rapid value assessment and price prediction

GPI horizon is a unique platform solution, based on our award-winning methodology, that quantifies an asset’s position in the market.

Using the latest technology and robust data sources, GPI horizon delivers rapid value assessment and price prediction to inform: portfolio strategy and prioritisation, investment decisions for early assets, strategic price and access planning for assets leading up to launch, price revisions throughout the product lifecycle. This makes GPI horizon perfect for not only price forecasting, but for quick and valuable insights throughout your asset's lifecycle.

See how GPI horizon works by viewing our research example, winner of the ISPOR research award.

GET A FREE ASSET EVALUATION WITH THE LAUNCH OF GPI HORIZON!

Schedule a free demo

Why use GPI horizon's value assessment & price prediction platform

Speed & Agility

Take a faster, data-driven approach to pricing and access research, using predictive payer analytics. Understand your asset’s position in the market from a clinical, price, and payer perspective.

Robust icon

Robustness

GPI horizon frameworks are validated by payers and country experts, incorporating a holistic view of payer value perception. The outputs are based on robust, objective data, adding to information gained from any payer interviews.

Transparent icon

Transparency

No black box - clear methodology, providing transparency and confidence across the business. GPI horizon leverages both GPI pulse™ and other external data sources (e.g. HTA documents, clinical peer-reviewed publications, etc.)

Flexible Icon

Flexibility

GPI horizon is applicable throughout the asset timeline, and can be adapted to most therapy areas. It can also be combined with GPI consulting service to inform strategic direction and considerations, providing for a truly bespoke solution.

Schedule a free demo

GPI horizon logo RGB small lores

GPI horizon provides a continuous, agile journey - underpinned by data

Traditional pricing and access activities are resource intensive and provide a snapshot in time. GPI horizon enables a faster and more agile way of working that is backed by GPI pulse™ data.

Wherever you are in the product lifecycle, and we’ll create the right solution for you:

BD&L Early Phase icon 2

BD&L / Early Pipeline

Pre-clinical – Early Phase 2

BD&L / Early Pipeline

• Rapid and more comprehensive asset evaluations to inform investment decisions

• Analogue selection supported by data from comprehensive GPI pulse™ database

• Test alternative scenarios and multiple assets quickly

• Transparent and payer-validated methodology

• Reduce internal burden and lengthy contracting

 

 

GPI horizon Late Phase icon

Late Phase

Phase 2-3

Late Phase

• Bespoke strategy and actionable recommendations from experienced P&MA consulting team

• Analogue selection supported by data from comprehensive GPI pulse™ database

• Faster project timelines leveraging analytical framework and readily available data

• Transparent and payer-validated methodology

• Rapid and continuous assessment of scenarios in response to evolving landscape

 

 

The challenges horizon overcomes

Need for faster insights

Need for instant, robust data for decision making

Increased pressure for P&MA teams to monitor landscape

Increased speed of drug launches

No analytical tools on the market to help

Leverage GPI horizon throughout the development lifecycle, and most therapy areas

Early Pipeline Use Cases

Rapidly-evaluate-icon

Rapidly evaluate price and access potential for an early asset

GPI horizon icon reduces bias

Weigh up several TPP (target product profile) scenarios to inform strategy

Selection of assets icon

Systematically prioritize a selection of assets for an optimized portfolio

Evidence icon 2

Generate evidence to enhance price potential with a clear understanding of payer value perception

Clinical Hurdles icon

Understand the clinical hurdles required to meet a certain price

Re-evaluate price 4

Quickly re-evaluate price and adjust your strategy due to an evolving landscape

Late Phase

Discussions icon

Optimise valuable payer research time with more streamlined discussions

GPI horizon icon reduces bias

Weigh up several TPP (target product profile) scenarios to inform strategy

Evidence based icon

Develop an evidence-based approach to negotiate price with payers

Evidence icon 2

Generate evidence to enhance price potential with a clear understanding of payer value perception

identify launch sequence

Identify the optimal subsequent launch indications to preserve price

Re-evaluate price 4

Quickly re-evaluate price and adjust your strategy due to an evolving landscape

How GPI horizon can be used

Self-serve platform subscription

Self-serve platform subscription

Evaluations completed by the user – instantly.

Serviced platform subscription

Serviced Platform Subscription

Evaluations completed on-demand by GPI consulting.

Time frame: 3-10 business days per evaluation

Bespoke pricing & market access strategy projects

Bespoke Pricing & Access Strategy Projects

Project delivered by GPI consulting.

Time frame: 8 weeks on average, subject to scope.

Get a complimentary asset evaluation as part of the GPI horizon platform launch

Engage with us

Register your interest
in GPI solutions

Sign up for
GPI updates